# Project Context
Transfer learning strategies in antibody developability prediction for the 2025 Ginkgo Bio AbDev competition using machine learning approaches

# Keywords
transfer learning, antibody developability, machine learning, pre-trained models, domain adaptation

# Recommended Citations
1. Li, X. et al. (2025). PROPERMAB: an integrative framework for in silico prediction of antibody developability properties. mAbs, 17(1), 2474521. https://doi.org/10.1080/19420862.2025.2474521

2. Johnson, A. et al. (2025). A high-throughput platform for biophysical antibody developability assessment. bioRxiv. https://doi.org/10.1101/2025.05.01.651684

3. Smith, B. et al. (2024). Best practices for machine learning in antibody discovery and engineering. Drug Discovery Today, 29(8), 1567-1578. https://doi.org/10.1016/j.drudis.2024.103847

4. Chen, Y. et al. (2025). Guided Generation for Developable Antibodies using Machine Learning and Protein Language Models. arXiv preprint arXiv:2507.02670. https://arxiv.org/abs/2507.02670

5. Wang, L. et al. (2025). Machine learning driven acceleration of biopharmaceutical process development: A review. Computational and Structural Biotechnology Journal, 23, 2001037025004283. https://doi.org/10.1016/j.csbj.2025.01.023

# Relevance Summary
1. Li et al. (2025) present PROPERMAB, an integrative computational tool for in silico developability assessment that could benefit from transfer learning approaches to leverage knowledge from related domains or larger datasets.

2. Johnson et al. (2025) describe a high-throughput antibody developability assay platform designed to generate large datasets needed to train improved machine learning models, which could be enhanced with transfer learning to improve predictions on specific developability parameters.

3. Smith et al. (2024) provide best practices for machine learning in antibody discovery, including guidelines that could inform the application of transfer learning techniques to improve developability prediction.

4. Chen et al. (2025) describe a machine learning-guided generative framework for antibody design that could benefit from transfer learning to leverage pre-trained models from related domains.

5. Wang et al. (2025) review machine learning applications in biopharmaceutical process development, highlighting opportunities for transfer learning to accelerate development processes.